Form 4: USANA Health Sciences Director Ding Xia Reports Stock Transactions

Director Ding Xia of USANA Health Sciences reports acquisition and disposal of common stock and restricted stock units on November 2, 2024.

Summary

• On November 2, 2024, Ding Xia, a director of USANA Health Sciences, engaged in transactions involving the company's stock.
• These transactions included the acquisition of 675 shares of common stock through the vesting of restricted stock units.
• Simultaneously, 169 shares were disposed of at a price of $37.29.
• Following these transactions, Ding Xia directly owns 3,534 shares of USANA common stock and 1,348 restricted stock units.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.

Industry Context

This filing is a routine disclosure of stock transactions by a company insider, as required by the SEC. It provides transparency to investors regarding the buying and selling activities of company directors.

Stakeholder Impact

• The transactions may have a minor impact on shareholders by slightly altering the ownership structure.
• The transactions do not directly impact employees, customers, suppliers, or creditors.

Key Dates